| ORIGINAL ARTICLE |
|
| Year : 2016 | Volume
: 3
| Issue : 1 | Page : 46-49 |
|
|
Outcomes of GnRH agonist and GnRH antagonist regimens for IVF in women aged up to 40
Érika Vieira de Souza Jordao, Hitomi Miura Nakagawa, Flavielly Souza Estrela, Raiene Barbosa de Morais, David Barreira Gomes-Sobrinho, Bruno Ramalho de Carvalho
GENESIS – Center for Assistance in Human Reproduction, Brasília, Distrito Federal, Brazil
Correspondence Address:
Bruno Ramalho de Carvalho
Bruno Ramalho de Carvalho. Genesis - Center for Assistance in Human Reproduction. SHLS 716, Bloco“L”, Salas “L” 328/331, Centro Clínico Sul - Ala Leste. Brasília, Distrito Federal
Brazil
 Source of Support: None, Conflict of Interest: None
DOI: 10.5530/ami.2016.1.11
|
|
|
Objective: To compare outcomes among good-prognosis patients undergoing in vitro fertilization and intracytoplasmic sperm injection followed by embryo transfer (IVF/ICSI-ET) in GnRH-agonist (GnRH-a) and GnRH-antagonist (GnRH-ant) regimens.
Methods: Retrospective analysis of 434 IVF/ICSI-ET cycles performed in a private center, in women aged up to 40: GnRH-a (n = 291) and GnRH-ant (n = 143). Pre-gestational, gestational and perinatal outcomes were evaluated. Statistical analysis was performed by unpaired t-test, Mann-Whitney test and Fisher's exact test. Significance was set at p < 0.05.
Results: GnRH-a regimen was associated with higher amounts of total oocytes (10.7 ± 5.7 vs 9.3 ± 5.7, p < 0.001), mature oocytes (8.2 ± 4,5 vs 6.8 ± 4.4, p < 0.001) and good quality embryos transferred (1.7 ± 0.8 vs 1.5 ± 0.9; p < 0.05). Rates of fertilization, embryo implantation and live births were also higher in GnRH-a (72.8%, 27.6% and 48.8%, respectively) compared to GnRH-ant (65.3%, 14.7% and 26.6%, respectively; p < 0.0001). There were no significant differences between rates of preterm delivery or low birth weight, comparing the two groups.
Conclusion: Our results suggest that the long GnRH-a regimen is the one that offers the best reproductive outcomes among in women aged up to 40 undergoing IVF/ICSI-ET.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
